Exondys 51

This page shows the latest Exondys 51 news and features for those working in and with pharma, biotech and healthcare.

CHMP backs Spark’s Luxturna, but rejects Sarepta again

Eteplirsen was approved in the US as Exondys 51 in 2016, although the decision came after FDA reviewers recommended that the drug be rejected as the evidence for its benefits was ... which there was no meaningful difference between Exondys and placebo in

Latest news

Pfizer abandons antibody for Duchenne

News of the setback spurred modest gains in the share price of Sarepta, which sells exon-skipping therapy Exondys 51 (eteplirsen) in the US and Europe, as well as PTC Therapeutics
Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m

Sarepta has made its name by launching the first ever FDA approved treatment for Duchenne muscular dystrophy, Exondys 51, and is now looking to expand its pipeline into other rare disease ... Sarepta has also just announced rising sales of Exondys 51,
Mallinckrodt doses first patient in muscular dystrophy trial

For now, the only approved therapies are Sarepta’s exon-skipping therapy Exondys 51 (eteplirsen), which has some controversy over its efficacy, PTC’s Translarna (ataluren), which is available in Europe
Summit plunges after Duchenne disappointment

Sarepta's investment in the field has been possible thanks to the FDA’s approval of the first US-approved Duchenne drug, Exondys 51, in 2016, despite controversies over its efficacy. ... The field is marked by the curiosity of the EMA having approved
Sarepta soars on positive Duchenne data

it’s already a player in DMD therapy with its exon-skipping Exondys 51 (eteplirsen) therapy – approved in the US but not the Europe – but that drug is only suitable for

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Latest Intelligence

Europe vs the US: New drug product approvals

Among the noteworthy orphan approvals are Exondys 51 (for the treatment of Duchenne muscular dystrophy, only approved in the US), Darzalex (for the treatment of multiple myeloma, approved in the US
Deal Watch February 2017

Licence. 145. Sarepta Therapeutics/ Gilead Sciences. PRV received when EXONDYS 51 was FDA approved for Duchenne muscular dystrophy.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Associate Scientific Director: Salary TBC

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Medical Writer - Creative and Scientific Projects: DOE

Market Access Consultant - Greater Manchester: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Healthcare PR Senior Account Manager: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Account Manager- 4 days per week or full-time: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Account Manager: Negotiable

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Director - Digital: Great salary and benefits

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Senior Medical Writer: Salary is DOE

Healthcare PR Director: £100, 000 – £120, 000 benefits

Graduate Scientific Editor: DOE

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Solaris Health looks at the gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...